Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Montis Biosciences Logo
Montis Biosciences Growth Score
56
CB Rank
46257
Heat Score
62
Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction.
Founded
obfuscation
PrivateGrant Meise, Vlaams-Brabant, Belgium1-10 www.montisbio.com/
Biotechnology
Oncology
Therapeutics
Overview

Montis Biosciences
Total Funding
obfuscation
Growth Score
56
Heat Score
62

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score56
-1 pts
in past quarter
Heat Score 62
-31 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Montis Biosciences

CB Rank
46257
Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction.
Founded
obfuscation
PrivateGrant Meise, Vlaams-Brabant, Belgium1-10 www.montisbio.com/
Biotechnology
Oncology
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Luc Dochez, Massimiliano Mazzone, Peter Carmeliet
About the Company
Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumours.
Contact Email info@montisbio.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Immune-Oncology Therapeutics Targeting Vascular Dysfunction
Therapeutics designed to modulate immune responses by targeting vascular dysfunction in cancer treatment.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Montis Biosciences Logo
Grant - Montis Biosciences
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Montis Biosciences Logo
Grant - Montis Biosciences
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Montis Biosciences Logo
Grant - Montis Biosciences
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Montis Biosciences Logo
Grant - Montis Biosciences
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Montis Biosciences Logo
Grant - Montis Biosciences
1
obfuscation
Agentschap Innoveren & OndernemenGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Montis Biosciences Logo
Grant - Montis Biosciences
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Montis Biosciences Logo
Grant - Montis Biosciences
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Montis Biosciences Logo
Grant - Montis Biosciences
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Montis Biosciences Logo
Grant - Montis Biosciences
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - Montis Biosciences Logo
Grant - Montis Biosciences
1
obfuscation
Agentschap Innoveren & OndernemenGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 5 Board Members and Advisors 1 Contacts 2

Employee Profiles

Board Members and Advisors

News

News and Press

News•Mar 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,456
418.15%
 in past month

IT Spend

$139KThis year, Montis Biosciences is projected to spend $139K on IT, according to Aberdeen.

Active Website Tech Count

4Montis Biosciences is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 10m, Pound Sterling, and  Japanese Yen.

Total IP

1Montis Biosciences has 1 registered patent in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Montis Biosciences's headquarters? Montis Biosciences is located in Meise, Vlaams-Brabant, Belgium.Who invested in Montis Biosciences? Montis Biosciences has 7 investors including Agentschap Innoveren & Ondernemen and  Pfizer Venture Investments.When was the last funding round for Montis Biosciences? Montis Biosciences closed its last funding round on
obfuscation
from a Grant round.Who are Montis Biosciences's competitors? Alternatives and possible competitors to Montis Biosciences may include Normunity, Xilio Therapeutics, and  Immune-Onc Therapeutics.How much funding has Montis Biosciences raised to date? Montis Biosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|